Amplification of the neuronal transcription factor MYCN induces malignant transformation of neuroblastoma cells and is used for disease stratification [57], and sensitivity of neuroblastoma cells to impaired polyamine metabolism has been demonstrated to correlate with extent of MYCN amplification [54]. Here, MYCN is linked to neuroblastoma.